Qian Si

440 total citations
8 papers, 171 citations indexed

About

Qian Si is a scholar working on Pharmacology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Qian Si has authored 8 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Immunology and Allergy. Recurrent topics in Qian Si's work include Cell Adhesion Molecules Research (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Qian Si is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Qian Si collaborates with scholars based in United States, Spain and Canada. Qian Si's co-authors include Jin Wu, Donna Carr, Mary Motyl, Richard A. Mumford, Michael K. Wismer, Paul Harradine, Jing Chen Xiao, Katherine Young, Matthew L. Rizk and Fred Racine and has published in prestigious journals such as Blood, Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Qian Si

8 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qian Si United States 6 58 55 49 45 43 8 171
Joseph Fanous Israel 9 29 0.5× 20 0.4× 134 2.7× 17 0.4× 86 2.0× 13 284
Jingxuan He China 9 20 0.3× 17 0.3× 138 2.8× 11 0.2× 30 0.7× 14 231
Hee Kyoung Jeon South Korea 7 13 0.2× 47 0.9× 119 2.4× 106 2.4× 17 0.4× 8 196
Joan Chen United States 6 24 0.4× 27 0.5× 140 2.9× 29 0.6× 65 1.5× 15 278
Sean T. Byrne United States 8 30 0.5× 99 1.8× 158 3.2× 147 3.3× 11 0.3× 9 317
Batia Gorovitz Israel 7 33 0.6× 52 0.9× 176 3.6× 43 1.0× 17 0.4× 9 278
Balachandra Chenna United States 7 21 0.4× 43 0.8× 152 3.1× 19 0.4× 5 0.1× 10 243
Vahid Kia Iran 10 13 0.2× 38 0.7× 229 4.7× 28 0.6× 6 0.1× 28 311
Sudhanshu Shukla United States 13 18 0.3× 81 1.5× 143 2.9× 88 2.0× 46 1.1× 23 337
Tamutenda Chidawanyika United States 8 23 0.4× 67 1.2× 259 5.3× 81 1.8× 13 0.3× 9 335

Countries citing papers authored by Qian Si

Since Specialization
Citations

This map shows the geographic impact of Qian Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Si more than expected).

Fields of papers citing papers by Qian Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Si. The network helps show where Qian Si may publish in the future.

Co-authorship network of co-authors of Qian Si

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Si. A scholar is included among the top collaborators of Qian Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Si. Qian Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Carr, Donna, Zufei Zhang, Qian Si, et al.. (2020). In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa. Open Forum Infectious Diseases. 7(11). ofaa469–ofaa469. 3 indexed citations
2.
Wu, Jin, Fred Racine, Michael K. Wismer, et al.. (2018). Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62(5). 46 indexed citations
3.
Mann, Paul A., Catherine A. McLellan, Sandra Koseoglu, et al.. (2014). Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis. ACS Infectious Diseases. 1(1). 59–72. 65 indexed citations
4.
Reger, Thomas S., Nicholas Stock, Bowei Wang, et al.. (2009). Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(3). 1173–1176. 7 indexed citations
5.
Venkatraman, Shankar, Alec D. Lebsack, Michael F. Gardner, et al.. (2009). Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3′,5′-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist. Bioorganic & Medicinal Chemistry Letters. 19(19). 5803–5806. 6 indexed citations
6.
Aprikyan, Andrew A.G., Vahagn Makaryan, Qian Si, et al.. (2007). Small Molecule Inhibitor of Neutrophil Elastase Restores Impaired Production of Human Myeloid Cells Observed in Severe Congenital Neutropenia.. Blood. 110(11). 664–664. 1 indexed citations
7.
Doherty, George, Ginger X. Yang, Sharon Tong, et al.. (2003). N-Isonicotinoyl-(l)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 13(11). 1891–1895. 11 indexed citations
8.
Pepinsky, R. Blake, Richard A. Mumford, Ling Ling Chen, et al.. (2002). Comparative Assessment of the Ligand and Metal Ion Binding Properties of Integrins α9β1 and α4β1. Biochemistry. 41(22). 7125–7141. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026